Appunti di Terapia
Terapia breve per la polmonite non complicata acquisita in comunità in età pediatrica: si può fare!
Short therapy for uncomplicated community-acquired pneumonia in paediatric age: it is possible!
Angela Troisi, Alessandra Iacono, Federico Marchetti
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
Febbraio 2023 | DOI: 10.53126/MEBXXVIF031
Abstract
The paper reports the results published in the journal JAMA Pediatrics in November 2022 of a systematic review and meta-analysis comparing brief therapy and prolonged therapy for the treatment of non-severe community-acquired pneumonia (CAP) with the same oral antibiotic. The results suggest the non-inferiority of a short versus a long cycle in children aged 2 to 59 months. In addition, short-term antibiotic therapy improves adherence, reduces adverse effects and drug costs, and reduces caregiver work absenteeism. Paediatricians should prescribe 5 days of antibiotic therapy with amoxicillin (90 mg/kg/day in 3 doses) for non-severe CAP, taking into account the results of several randomized clinical trials that are now available.
Riassunto
Si riportano i risultati pubblicati sulla rivista JAMA Pediatrics nel mese di novembre 2022 di una revisione sistematica e di una metanalisi che mettono a confronto per la cura della polmonite acquisita in comunità (CAP) non grave la terapia breve e la terapia prolungata utilizzando lo stesso antibiotico orale. I risultati suggeriscono la non inferiorità di un ciclo breve rispetto a quello lungo nei bambini di età compresa tra 2 e 59 mesi. Inoltre, la terapia antibiotica di breve durata migliora l’aderenza, riduce gli effetti avversi e i costi del farmaco e l’assenteismo lavorativo del caregiver. I pediatri dovrebbero prescrivere 5 giorni di terapia antibiotica con amoxicillina (90 mg/kg/giorno in 3 dosi) per la CAP non grave, alla luce dei risultati dei diversi studi clinici randomizzati ora disponibili.
Contenuto riservato
Per leggere l'articolo è necessario effettuare il login.
Per l'acquisto del singolo articolo scrivi a
abbonamenti@medicoebambino.com
(la mail si prepara da sola con gli estremi dell'articolo);
se accedi, la richiesta parte con un click.
Classificazione MeSH
Bibliografia
- Iacono A, Troisi A, Marchetti F. La polmonite acquisita in comunità. Medico e Bambino 2021;40(8):515-8. doi: 10.53126/MEB40515.
- Pernica JM, Harman S, Kam AJ et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia: The SAFER Randomized Clinical Trial. JAMA Pediatr 2021;175(5):475-82. doi: 10.1001/jamapediatrics.2020.6735.
- Li Q, Zhou Q, Florez ID, Mathew JL et al. Short-course vs long-course antibiotic therapy for children with nonsevere community-acquired pneumonia: a systematic review and meta-analysis. JAMA Pediatr 2022;176(12):1199-207. doi: 10.1001/jamapediatrics.2022.4123.
- Williams DJ, Creech CB, Walter EB, et al.; The DMID 14-0079 Study Team. The DMID 14-0079 Study Team. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr 2022;176(3):253-261. doi:10.1001/jamapediatrics. 2021.5547.
- Bielicki JA, StöhrW, Barratt S, et al; PERUKI, GAPRUKI, and the CAP-IT Trial Group. Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial. JAMA 2021;326(17):1713-24. doi: 10.1001/jama.2021.17843.
- Ginsburg AS, Mvalo T, Nkwopara E, et al. Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in Malawian children. N Engl J Med 2020;383(1):13-23. doi: 10.1056/NEJMoa1912400.
- Greenberg D, Givon-Lavi N, Sadaka Y, et al. Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial. Pediatr Infect Dis J 2014;33(2):136-42. doi: 10.1097/INF.0000000000000023.
- Agarwal G, Awasthi S, Kabra SK, et al.; ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004;328(7443):791. doi: 10.1136/bmj.38049.490255.DE.
- WHO. Kartasasmita C, Saha S; Short Course Cotrimoxazole Study Group (eds). Consultative meeting to review evidence and research priorities in the management of acute respiratory infections (ARI). Accessed May 17, 2022.
- Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) Pneumonia Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360(9336):835-41. doi: 10.1016/S0140-6736(02)09994-4.
- Lupisan SP, Medalla FM, Miguel CA, et al. A randomised, placebo-controlled trial of short course cotrimoxazole for the treatment of pneumonia in Filipino children. Philipp J Microbiol Infect Dis 1999;28:15-20.
- Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008;(2):CD005976. doi: 10.1002/14651858.CD005976.pub2.
- Harris M, Clark J, Coote N, et al.; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011;66 Suppl2:ii1-23. doi: 10.1136/thoraxjnl-2011-200598.
- Bradley JS, Byington CL, Shah SS, et al.; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Paediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53(7): 617-30. doi: 10.1093/cid/cir625.
- Murphy S, Thomson L. NICE community-acquired pneumonia guideline review. Arch Dis Child Educ Pract Ed 2021;106(5):296-8. doi: 10.1136/archdischild-2020-319376.
- World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries. Accessed May 17, 2022.
- Florin TA, Ambroggio L, Brokamp C, et al. Biomarkers and disease severity in children with community-acquired pneumonia. Pediatrics 2020;145(6):e20193728. doi: 10.1542/peds.2019-3728.
- Farneti C, Vieni G, Marchetti F. La radiografia del torace nella broncopolmonite: inutile nella maggioranza dei casi? Medico e Bambino 2018;37(2):93-5.